Select Page
Albensi paper suggests how Covid-related neurological symptoms such as headaches, coma and brain-fog could be treated with therapeutics targeting pathways prone to inflammation.

Albensi paper suggests how Covid-related neurological symptoms such as headaches, coma and brain-fog could be treated with therapeutics targeting pathways prone to inflammation.

The paper titled: The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease was published today in a special issue on COVID-19, in Molecular Neurobiology, and shows how therapeutics that reduce the NF-κB pathway should be considered in the treatment...
Study warns of significant dementia increase

Study warns of significant dementia increase

The number of Manitobans living and affected by dementia is projected to dramatically increase, according to a study recently published in Neuroepidemiology (Karger). The largest increase is projected to occur in the 75–84 years of age group with a growth of 98.83% by...
Glazner featured in FP article on Meth

Glazner featured in FP article on Meth

Dr. Gordon Glazner, Principal Investigator, Cellular Neuropathology & Neurodegeneration, Division of Neurodegenerative Disorders, was featured in the Winnipeg Free Press this past weekend in a full-page article on the destructive effects of methamphetamine on the...